Advertisement
Advertisement

MOLN

MOLN logo

Molecular Partners AG - ADR

3.79
USD
Sponsored
0.00
-0.13%
Jun 25, 09:39 UTC -4
Open

MOLN Earnings Reports

Positive Surprise Ratio

MOLN beat 4 of 4 last estimates.

100%

Next Report

Date of Next Report
Aug 25, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

Molecular Partners AG - ADR earnings per share and revenue

On Mar 12, 2026, MOLN reported earnings of -0.23 USD per share (EPS) for Q4 25, beating the estimate of -0.34 USD, resulting in a 32.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.40% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q4 2025, Molecular Partners AG - ADR reported EPS of -$0.23, beating estimates by 32.53%, and revenue of $0.00, 0% as expectations.
The stock price moved down -10.4%, changed from $4.71 before the earnings release to $4.22 the day after.
The next earning report is scheduled for Aug 25, 2026.
Based on -- analysts, Molecular Partners AG - ADR is expected to report EPS of -- and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement